l carnitine and drinking alcohol in Use Disorders: A Scoping Review The cold does not scare

1371-C NON-ALCOHOL FATTY LIVER DISEASE IN A PROSPECTIVE NATIONAL COHORT OF HEPATITIS B PATIENTS WITH SUBOPTIMAL RESPONSE TO ANTIVIRAL THERAPY Wen Xie, Center of Liver Diseases, Beijing Ditan Hospital, Capital Medical University, Beijing, China, Lihua Cao, The Third Hospital of Qinhuangdao City, Hebei, China, Shuangsuo Dang, The Second Affiliated Hospital of Xi'an Jiaotong University, Shaanxi, China, Liying Zhu, The Second Affiliated Hospital of Harbin Medical University, Heilongjiang, China, Dongliang Yang, Union Hospital Affiliated to Tongji Medical College, Huazhong University of Science and Technology, Hubei, China, Yueyong Zhu, The First Affiliated Hospital of Fujian Medical University, Fujian, China, Xiaoguang Dou, Shengjing Hospital Affiliated with China Medical University, Liaoning, China, Zhiliang Gao, The Third Affiliated Hospital of Sun Yat-Sen University, Guangdong, China, Binbin Chen, Guangzhou Eighth People's Hospital, Guangzhou Medical University, Xinxin Zhang, Ruijin Hospital, Shanghai Jiaotong University School of Medicine, Yuming Wang, Chongqing Public Health Medical Center, Chongqing, China, Yan Liu, Department of Infectious Diseases, the Fifth Medical Center of Chinese PLA General Hospital, Beijing, China, Ting Zhang, Center of Liver Diseases Division, Beijing Ditan Hospital, Capital Medical University, Beijing, China and Calvin Pan Pan, New York University Langone Medical Center, Flushing, NY Background: The non-alcohol fatty liver disease (NAFLD) had been reported in 27% of Chinese adults with chronic hepatitis B (CHB)

The ideal way to do this is to talk to a healthcare professional

For completeness, we also evaluate GPT-4.1 mini in a zero-shot setting on the same classification task

US life expectancy stalls due to cardiovascular disease, not drug deaths